Keywords: Strides Arcolab, Inbiopro, Biologics, Biosimilars, Cancer drugs

Strides Arcolab expands in biologics, buying 70% stake in Bangalore’s Inbiopro

Article | 10 December 2010

Indian drugmaker Strides Arcolab Limited (BSE: 532531, NSE: STAR) has entered into an agreement to acquire 70% stake in Bangalore-based biotechnology firm ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Strides Arcolab

Inbiopro Solutions

Go to company listing